Edgewell FY26 Q3 GAAP diluted EPS drops 43.48% to USD 0.26; net sales rise 1.7% to USD 570.1 million

• Edgewell posted fiscal 3Q 2026 GAAP diluted EPS of USD 0.26, down from USD 0.46 a year earlier.
• Net sales rose 1.7% to USD 570.1 million, with organic net sales up 1.1%.
• GAAP operating income fell to USD 25 million from USD 45 million, including USD 24.5 million of pre-tax restructuring and related costs.
• Non-GAAP adjusted EPS held at USD 0.72; non-GAAP adjusted EBITDA eased to USD 78.9 million from USD 81.2 million.
• Full-year outlook narrowed: net sales growth seen at 1.3%-1.8%; non-GAAP adjusted EPS forecast at USD 1.80-USD 2.00.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewell Personal Care Company published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.